These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 23635789)

  • 21. Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche.
    Govaere O; Wouters J; Petz M; Vandewynckel YP; Van den Eynde K; Van den Broeck A; Verhulst S; Dollé L; Gremeaux L; Ceulemans A; Nevens F; van Grunsven LA; Topal B; Vankelecom H; Giannelli G; Van Vlierberghe H; Mikulits W; Komuta M; Roskams T
    J Hepatol; 2016 Mar; 64(3):609-17. PubMed ID: 26592953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD34(+) Liver Cancer Stem Cells Were Formed by Fusion of Hepatobiliary Stem/Progenitor Cells with Hematopoietic Precursor-Derived Myeloid Intermediates.
    Zeng C; Zhang Y; Park SC; Eun JR; Nguyen NT; Tschudy-Seney B; Jung YJ; Theise ND; Zern MA; Duan Y
    Stem Cells Dev; 2015 Nov; 24(21):2467-78. PubMed ID: 26192559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovatodiolide suppresses yes-associated protein 1-modulated cancer stem cell phenotypes in highly malignant hepatocellular carcinoma and sensitizes cancer cells to chemotherapy in vitro.
    Chang HL; Chen HA; Bamodu OA; Lee KF; Tzeng YM; Lee WH; Tsai JT
    Toxicol In Vitro; 2018 Sep; 51():74-82. PubMed ID: 29698666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RACK1 Promotes Self-Renewal and Chemoresistance of Cancer Stem Cells in Human Hepatocellular Carcinoma through Stabilizing Nanog.
    Cao J; Zhao M; Liu J; Zhang X; Pei Y; Wang J; Yang X; Shen B; Zhang J
    Theranostics; 2019; 9(3):811-828. PubMed ID: 30809310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer stem cells in human gastrointestinal cancer.
    Taniguchi H; Moriya C; Igarashi H; Saitoh A; Yamamoto H; Adachi Y; Imai K
    Cancer Sci; 2016 Nov; 107(11):1556-1562. PubMed ID: 27575869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer cells stemness: A doorstep to targeted therapy.
    Prasad S; Ramachandran S; Gupta N; Kaushik I; Srivastava SK
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165424. PubMed ID: 30818002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Progress and prospects in cancer stem cell research for hepatocellular carcinoma].
    Xu W; Cao L; Yin ZF
    Ai Zheng; 2009 Sep; 28(9):1004-8. PubMed ID: 19728923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
    Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
    EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of mitochondria in liver cancer stem cells.
    Chang CW; Lo JF; Wang XW
    Differentiation; 2019; 107():35-41. PubMed ID: 31176254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective.
    Chiba T; Kamiya A; Yokosuka O; Iwama A
    Cancer Lett; 2009 Dec; 286(2):145-53. PubMed ID: 19464789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-206 inhibits liver cancer stem cell expansion by regulating EGFR expression.
    Liu C; Li J; Wang W; Zhong X; Xu F; Lu J
    Cell Cycle; 2020 May; 19(10):1077-1088. PubMed ID: 32286127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer stem cells in breast cancer.
    Dittmer J; Rody A
    Histol Histopathol; 2013 Jul; 28(7):827-38. PubMed ID: 23468411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pluripotency inducing Yamanaka factors: role in stemness and chemoresistance of liver cancer.
    Fatma H; Siddique HR
    Expert Rev Anticancer Ther; 2021 Aug; 21(8):853-864. PubMed ID: 33832395
    [No Abstract]   [Full Text] [Related]  

  • 34. Stemness in Liver Cancer.
    Thorgeirsson SS
    Dig Dis; 2017; 35(4):387-389. PubMed ID: 28467999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index.
    Bai KH; He SY; Shu LL; Wang WD; Lin SY; Zhang QY; Li L; Cheng L; Dai YJ
    Cancer Med; 2020 Jun; 9(12):4290-4298. PubMed ID: 32311840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of stem cells in normal liver and cancer.
    Lau CK; Yang ZF; Fan ST
    Anticancer Agents Med Chem; 2011 Jul; 11(6):522-8. PubMed ID: 21554200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer.
    Marquardt JU; Gomez-Quiroz L; Arreguin Camacho LO; Pinna F; Lee YH; Kitade M; Domínguez MP; Castven D; Breuhahn K; Conner EA; Galle PR; Andersen JB; Factor VM; Thorgeirsson SS
    J Hepatol; 2015 Sep; 63(3):661-9. PubMed ID: 25937435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver cancer stem cells as an important target in liver cancer therapies.
    Zou GM
    Anticancer Agents Med Chem; 2010 Feb; 10(2):172-5. PubMed ID: 20298161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular matrix-mediated regulation of cancer stem cells and chemoresistance.
    Brown Y; Hua S; Tanwar PS
    Int J Biochem Cell Biol; 2019 Apr; 109():90-104. PubMed ID: 30743057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.